tiprankstipranks
Advertisement
Advertisement

HK:1877 Stock Latest News

Junshi Biosciences’ Major Shareholder Lets Share-Sale Plan Expire Unused
Company AnnouncementsJunshi Biosciences’ Major Shareholder Lets Share-Sale Plan Expire Unused
3d ago
Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase
PremiumCompany Announcements
Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase
13d ago
Shanghai Junshi Biosciences Schedules 2025 Results Briefing for Investor Q&A
PremiumCompany Announcements
Shanghai Junshi Biosciences Schedules 2025 Results Briefing for Investor Q&A
24d ago
Junshi Biosciences Chairman Continues Shareholding Increase Plan
PremiumCompany Announcements
Junshi Biosciences Chairman Continues Shareholding Increase Plan
28d ago
Junshi Biosciences Board Approves 2025 Work Report and Highlights Governance Actions
PremiumCompany Announcements
Junshi Biosciences Board Approves 2025 Work Report and Highlights Governance Actions
1M ago
Shanghai Junshi Biosciences Details Board and Committee Structure
PremiumCompany AnnouncementsShanghai Junshi Biosciences Details Board and Committee Structure
1M ago
Shanghai Junshi Biosciences Sets Terms for New Strategic and ESG Board Committee
Premium
Company Announcements
Shanghai Junshi Biosciences Sets Terms for New Strategic and ESG Board Committee
1M ago
Junshi Biosciences Adds ESG Focus and Revamps Pay Policies
Premium
Company Announcements
Junshi Biosciences Adds ESG Focus and Revamps Pay Policies
1M ago
Shanghai Junshi Biosciences Lifts Revenue and Narrows Loss as Immuno-Oncology Pipeline Advances
PremiumCompany Announcements
Shanghai Junshi Biosciences Lifts Revenue and Narrows Loss as Immuno-Oncology Pipeline Advances
1M ago
Junshi Biosciences Details Use and Return of Idle Fundraising Proceeds for Liquidity
PremiumCompany Announcements
Junshi Biosciences Details Use and Return of Idle Fundraising Proceeds for Liquidity
1M ago
Junshi Biosciences Chairman Continues Incremental Share Purchase Plan
PremiumCompany Announcements
Junshi Biosciences Chairman Continues Incremental Share Purchase Plan
1M ago
Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China
PremiumCompany Announcements
Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China
1M ago
Shanghai Junshi announces NMPA acceptance of NDAs for toripalimab injection
PremiumThe FlyShanghai Junshi announces NMPA acceptance of NDAs for toripalimab injection
1M ago
Shanghai Junshi Biosciences Sets March 2026 Board Meeting to Approve 2025 Results
Premium
Company Announcements
Shanghai Junshi Biosciences Sets March 2026 Board Meeting to Approve 2025 Results
1M ago
Junshi Biosciences Narrows 2025 Loss as Revenue Climbs Nearly 30%
Premium
Company Announcements
Junshi Biosciences Narrows 2025 Loss as Revenue Climbs Nearly 30%
1M ago
Junshi Biosciences Chairman Progresses RMB100 Million Shareholding Increase Plan
PremiumCompany Announcements
Junshi Biosciences Chairman Progresses RMB100 Million Shareholding Increase Plan
2M ago
Junshi Biosciences Forecasts Strong 2025 Revenue Growth and Narrowing Loss on TUOYI Sales
PremiumCompany Announcements
Junshi Biosciences Forecasts Strong 2025 Revenue Growth and Narrowing Loss on TUOYI Sales
2M ago
Shanghai Junshi Biosciences Raises RMB1 Billion via Technology Innovation Bonds
PremiumCompany Announcements
Shanghai Junshi Biosciences Raises RMB1 Billion via Technology Innovation Bonds
3M ago
Junshi Biosciences Chairman Starts Shareholding Increase Plan
PremiumCompany Announcements
Junshi Biosciences Chairman Starts Shareholding Increase Plan
3M ago
Junshi Biosciences Extends Timeline for Deployment of 2022 A-Share Proceeds
PremiumCompany AnnouncementsJunshi Biosciences Extends Timeline for Deployment of 2022 A-Share Proceeds
3M ago
Shanghai Junshi Biosciences Wins Approval to Register RMB20 Billion in Tech Innovation Bonds
Premium
Company Announcements
Shanghai Junshi Biosciences Wins Approval to Register RMB20 Billion in Tech Innovation Bonds
4M ago
Junshi Biosciences’ 5%+ Shareholder Plans Stake Reduction of Up to 2% via Block Trades
Premium
Company Announcements
Junshi Biosciences’ 5%+ Shareholder Plans Stake Reduction of Up to 2% via Block Trades
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >